Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
